| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |